AngioDynamics, Inc. (ANGO)
15.11
-0.01
(-0.07%)
USD |
NASDAQ |
Oct 02, 16:00
15.12
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Net Income (Quarterly) : -11.40M for May 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -11.40M |
| February 28, 2026 | -8.084M |
| November 30, 2025 | -6.35M |
| August 31, 2025 | -10.90M |
| May 31, 2025 | -6.05M |
| February 28, 2025 | -4.407M |
| November 30, 2024 | -10.74M |
| August 31, 2024 | -12.80M |
| May 31, 2024 | -13.45M |
| February 29, 2024 | -187.74M |
| November 30, 2023 | -29.05M |
| August 31, 2023 | 45.88M |
| May 31, 2023 | -21.47M |
| February 28, 2023 | -9.485M |
| November 30, 2022 | -8.486M |
| August 31, 2022 | -13.00M |
| May 31, 2022 | -6.266M |
| February 28, 2022 | -4.958M |
| November 30, 2021 | -8.351M |
| August 31, 2021 | -6.972M |
| May 31, 2021 | -19.47M |
| February 28, 2021 | -3.544M |
| November 30, 2020 | -4.268M |
| August 31, 2020 | -4.268M |
| May 31, 2020 | -156.07M |
| Date | Value |
|---|---|
| February 29, 2020 | -5.709M |
| November 30, 2019 | -2.736M |
| August 31, 2019 | -1.275M |
| May 31, 2019 | 2.753M |
| February 28, 2019 | -4.609M |
| November 30, 2018 | -3.587M |
| August 31, 2018 | -5.704M |
| May 31, 2018 | -2.483M |
| February 28, 2018 | 14.02M |
| November 30, 2017 | 0.249M |
| August 31, 2017 | -0.035M |
| May 31, 2017 | -12.91M |
| February 28, 2017 | 2.887M |
| November 30, 2016 | 13.73M |
| August 31, 2016 | 1.30M |
| May 31, 2016 | -43.08M |
| February 29, 2016 | 0.594M |
| November 30, 2015 | -0.362M |
| August 31, 2015 | -0.757M |
| May 31, 2015 | -0.814M |
| February 28, 2015 | -4.262M |
| November 30, 2014 | 1.338M |
| August 31, 2014 | 0.47M |
| May 31, 2014 | -1.078M |
| February 28, 2014 | 5.108M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Boston Scientific Corp. | 905.00M |
| Penumbra, Inc. | 34.81M |
| Abbott Laboratories | 928.00M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 86.61M |
| Total Expenses (Quarterly) | 98.01M |
| EPS Diluted (Quarterly) | -0.2735 |
| Enterprise Value | 587.18M |
| Gross Profit Margin (Quarterly) | 50.87% |
| Profit Margin (Quarterly) | -13.17% |
| Earnings Yield | -5.86% |
| Normalized Earnings Yield | -3.960 |